Park Ha Biological Technology Faces Pump-and-Dump Lawsuit
Pomerantz Law Firm filed a class action against BYAH over alleged social media manipulation that inflated the stock after its IPO.
If you bought shares of Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) and watched your investment crater, you're not alone — and there may be legal recourse worth knowing about. Pomerantz LLP has filed a class action lawsuit against the company on behalf of investors who took losses, and the clock is ticking on a key deadline.
The lawsuit paints a pretty alarming picture. According to the complaint, Park Ha was allegedly caught up in a classic "pump-and-dump" scheme — the kind where bad actors artificially inflate a stock's price, then cash out before regular investors know what hit them. In this case, the alleged manipulation involved social media misinformation and individuals posing as financial professionals to hype the stock following its initial public offering (IPO). Once the hype faded, so did the share price — leaving everyday investors holding the bag.
Read more HCW Biologics Files to Register 1.24M Shares From PIPE Deal →
Pump-and-dump schemes are unfortunately not new, but they've gotten harder to spot in the age of social media, where a convincing post from a fake "analyst" account can move markets faster than any press release. If the allegations against BYAH hold up, it's a reminder to always be skeptical of investment tips that seem to come out of nowhere online.
Here's the part that directly affects you if you're an affected investor: you have until **September 28, 2026**, to seek appointment as Lead Plaintiff in the class action. Being Lead Plaintiff means you'd represent the broader group of investors in the suit, though you can still participate in any recovery even if you don't take that role. It's worth talking to a securities attorney sooner rather than later to understand your options.
Continue reading at PR Newswire.
